Table 4.

Engraftment, hospitalization time, and transplantation-related toxicity

Arm A
HDM140/TBI
(n = 140)
Arm B
HDM200
(n = 142)
P
G/GM-CSF (%) 111 (79) 107 (75) .52  
Duration of G/GM-CSF, d (median) 0-25 (8) 0-23 (7) .37  
Duration of neutropenia, d (median) 4-34 (10) 4-34 (8) < .001  
Duration of thrombocytopenia, d
(median) 
0-110 (7) 0-30 (7) < .001 
No. of platelet transfusions
(median) 
0-30 (2) 0-18 (1) < .001  
No. of red blood cell transfusions
(median) 
2 (0-22) 2 (0-9) < .001 
Duration of hospitalization, d
(median) 
12-77 (23) 11-47 (19) < .001  
Duration of intravenous
antibiotics, d (median) 
0-60 (11) 0-30 (8) < .001  
Cardiac toxicity grade 3-4 (%) 5 (3.6) 1 (0.7) .21   
Mucositis grade 3-4 (%) 71 (51) 42 (30) < .001  
Pulmonary toxicity grade 3-4 (%) 9 (6.4) 2 (1.4) .06   
Renal toxicity grade 3-4 (%) 5 (3.6) 3 (2.1) .7    
Liver toxicity grade 3-4 (%) 2 (1.4) 1 (0.7) .99   
Toxic death (%) 5 (3.6) .07  
Arm A
HDM140/TBI
(n = 140)
Arm B
HDM200
(n = 142)
P
G/GM-CSF (%) 111 (79) 107 (75) .52  
Duration of G/GM-CSF, d (median) 0-25 (8) 0-23 (7) .37  
Duration of neutropenia, d (median) 4-34 (10) 4-34 (8) < .001  
Duration of thrombocytopenia, d
(median) 
0-110 (7) 0-30 (7) < .001 
No. of platelet transfusions
(median) 
0-30 (2) 0-18 (1) < .001  
No. of red blood cell transfusions
(median) 
2 (0-22) 2 (0-9) < .001 
Duration of hospitalization, d
(median) 
12-77 (23) 11-47 (19) < .001  
Duration of intravenous
antibiotics, d (median) 
0-60 (11) 0-30 (8) < .001  
Cardiac toxicity grade 3-4 (%) 5 (3.6) 1 (0.7) .21   
Mucositis grade 3-4 (%) 71 (51) 42 (30) < .001  
Pulmonary toxicity grade 3-4 (%) 9 (6.4) 2 (1.4) .06   
Renal toxicity grade 3-4 (%) 5 (3.6) 3 (2.1) .7    
Liver toxicity grade 3-4 (%) 2 (1.4) 1 (0.7) .99   
Toxic death (%) 5 (3.6) .07  

or Create an Account

Close Modal
Close Modal